Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Language
Document Type
Year range
1.
American Journal of Pharmaceutical Education ; 85(10):1143-1149, 2021.
Article in English | ProQuest Central | ID: covidwho-1627979

ABSTRACT

[...]of the ongoing pandemic, members met virtually throughout the 2020-2021 academic year to begin developing a framework and plan to address each of the 4 charges. CHARGE 2 SUBGROUP Background As the COVID-19 pandemic unfolded in the United States (US) in 2020, unprecedented federal expansion of scope of practice ("Scope") for pharmacists has been implemented by the US Department of Health and Human Services (DHHS) via the PREP Act. While the federal government has covered the cost of the vaccines and has provided supplemental funding to support access during the COVID-19 pandemic, payment for advanced patient care services provided by pharmacists in the future will be necessary for these services to be sustainable. CPAs * Continue to support the model that allows all licensed pharmacists with appropriate training to participate in CPAs, and does not restrict participation to subset of licensed pharmacists * Continue supporting the population model of CPAs which increases patient access and does not add undue regulatory burden to the process * Discourage use of patient-specific CPAs in meeting public health needs o Patient-specific CPAs are ineffective during a public health emergency * Encourage state boards of pharmacy to outline

2.
Am J Pharm Educ ; 85(10): 8715, 2021 11.
Article in English | MEDLINE | ID: covidwho-1323405

ABSTRACT

EXECUTIVE SUMMARY For the American Association of Colleges of Pharmacy (AACP), strategic engagement is critical to the success of colleges and schools of pharmacy in expanding pharmacy and public health practice, meeting programmatic needs, and fulfilling institutional missions. The 2020-2021 Strategic Engagement Standing Committee was charged with identifying effective strategies to leverage the temporary expansion of pharmacist practice capabilities granted during the COVID-19 pandemic for sustained practice. The group was also tasked with looking at ways to partner with the Association of American Medical Colleges (AAMC), our medicine counterparts to develop a plan for collaborating with them to advance interprofessional practice. In this unique year, all standing committees were charged with reading all the reports last year to put President Lin's charges into perspective with the hopes of carrying over the overall theme and work of the previous years committee. Overall, throughout the COVID-19 pandemic, there have been several expansions on the scope of practice for pharmacists and vary by state. We hope to draw out some of those expansions to see how we can build upon efforts to make those permanent.


Subject(s)
COVID-19 , Education, Pharmacy , Advisory Committees , Humans , Pandemics , Pharmacists , SARS-CoV-2 , Schools, Pharmacy , Societies, Pharmaceutical , United States
SELECTION OF CITATIONS
SEARCH DETAIL